title: Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine.
abstract: New psychoactive substances (NPS) have become an increasing drug problem in the past decade. For detection of NPS, new analytical methods have to be developed, and the methods also have to be updated regularly. This study aimed at developing a multi-component LC-MS/MS method for detection and quantification of 11 NPS of the benzodiazepine sub-class ("designer benzodiazepines") in urine specimens. The method involves dilution of urine with internal standard and hydrolysis of any glucuronide conjugated forms. Separation of the compounds was achieved on a BEH Phenyl column, followed by MS/MS detection in positive electrospray mode. Method validation was performed following the EMA guideline. The method was applied to study the occurrence of designer benzodiazepines in Sweden in 2014-2015, by analysis of 390 samples retrieved from a routine drug testing laboratory. In 40% of these samples, selected based on a positive immunoassay benzodiazepine screening but a negative MS confirmation for the standard set of prescription benzodiazepines, intake of designer benzodiazepines was revealed. These results stress the importance of using and updating confirmation methods to include the increasing number of designer benzodiazepines appearing on the NPS market.
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet, Stockholm, Sweden. Electronic address: madeleine.pettersson.bergstrand@ki.se.
authors.forename: Madeleine
authors.initials: M
authors.lastname: Pettersson Bergstrand
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Pharmacology, Karolinska University Laboratory, Stockholm, Sweden.
authors.forename: Anders
authors.initials: A
authors.lastname: Helander
authors.affiliation: Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Pharmacology, Karolinska University Laboratory, Stockholm, Sweden.
authors.forename: Olof
authors.initials: O
authors.lastname: Beck
mesh_terms: D001569:Benzodiazepines / Q000652:urine*; D002845:Chromatography / Q000379:methods*; D006801:Humans; D012015:Reference Standards; D015203:Reproducibility of Results; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: D001569:Benzodiazepines
keywords: Designer benzodiazepines; Drug testing; LC–MS/MS; NPS; Urine